XML 152 R126.htm IDEA: XBRL DOCUMENT v3.25.1
Equity - Additional Information (Detail) - BRL (R$)
R$ / shares in Units, R$ in Thousands
12 Months Ended
Aug. 07, 2024
Apr. 17, 2024
Feb. 28, 2024
Aug. 09, 2023
Apr. 19, 2023
Feb. 15, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of classes of share capital [line items]                  
Rights, preferences and restrictions attaching to class of share capital             Each common share entitles its holder to one vote at Shareholders’ Meetings.    
Increase in capital reserves             R$ 112,160 R$ 24,303  
Treasury shares             (596,400) (470,510)  
Dividends payable               R$ 439,684 R$ 109,515
Dividends per share               R$ 0.4 R$ 0.1
Proposed dividends payable             R$ 493,301 R$ 439,684 R$ 109,515
Proposed dividends payable per share             R$ 0.45 R$ 0.4 R$ 0.1
Legal reserve as percentage of net income             5.00% 5.00% 5.00%
Threshold percentage of share capital for legal reserve allocation             20.00%    
Legal reserves             R$ 240,127 R$ 121,990  
Investments statutory reserve as maximum percentage of net income             75.00%    
Threshold percentage of share capital for investments reserve allocation             100.00%    
Increase in Company's capital         R$ 1,450,000        
Minimum mandatory dividends as percentage of net income             25.00% 25.00% 25.00%
Outstanding shares price per share             R$ 15.88 R$ 26.51 R$ 12.61
Dividend paid per share R$ 0.25                
Extrafarma [member]                  
Disclosure of classes of share capital [line items]                  
Increase in capital reserves R$ 821   R$ 5,631 R$ 149   R$ 411      
Incurred costs directly attributable to issuing new shares             R$ 2,260    
Treasury shares                  
Disclosure of classes of share capital [line items]                  
Shares held in treasury             19,283,471 16,195,439 19,974,556
Average cost             R$ 17.87    
Treasury shares             R$ (596,400) R$ (470,510)  
Description buyback program of shares             On November 28, 2024, the Company's Board of Directors approved a buyback program of shares issued by the Company, effective for twelve months starting on December 2, 2024 and limited to a maximum of 25,000,000 common shares.    
Shares buyback program authorized common shares             25,000,000    
Shares Buyback program number of shares acquired             8,900,000    
Shares Buyback program average price per share             R$ 16.74    
Capital reserve | Extrafarma [member]                  
Disclosure of classes of share capital [line items]                  
Increase in capital reserves             R$ 498,812    
Investments statutory reserve                  
Disclosure of classes of share capital [line items]                  
Retention of profits and investments reserve             R$ 7,746,973 R$ 6,267,569  
Increase in Company's capital         567,425        
Legal Reserve                  
Disclosure of classes of share capital [line items]                  
Increase in Company's capital         R$ 882,575        
Common shares [member]                  
Disclosure of classes of share capital [line items]                  
Subscribed and paid-in capital stock             1,115,439,503 1,115,212,490  
Par value per share             R$ 0    
Common shares outstanding             65,757,889 52,197,033 58,895,761
Payment of dividends R$ 275,971 R$ 134,031              
Dividend payable date Aug. 23, 2024                
Common shares [member] | Treasury shares                  
Disclosure of classes of share capital [line items]                  
Balance of treasury shares granted with right of use             14,083,439 9,515,384  
Shares held in treasury             19,283,471 16,195,439